Nalmefene (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nalmefene" in Italian language version.

refsWebsite

Global rank Italian rank

8nih.gov

4^th place

9^th place

4oadoi.org

799^th place

22^nd place

4doi.org

2^nd place

7^th place

1espacenet.com

800^th place

1,504^th place

1clinicaltrials.gov

5,225^th place

5,296^th place

1web.archive.org

1^st place

clinicaltrials.gov

Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling, su clinicaltrials.gov.

doi.org

dx.doi.org

N. Donnerstag, T. Schneider; A. Lüthi; A. Taegtmeyer; A. Raetz Bravo; A. Mehlig, Severe opioid withdrawal syndrome after a single dose of nalmefene., in Eur J Clin Pharmacol, vol. 71, n. 8, Aug 2015, pp. 1025-6, DOI:10.1007/s00228-015-1884-1, PMID 26050241.
C. Palpacuer, B. Laviolle; R. Boussageon; JM. Reymann; E. Bellissant; F. Naudet, Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials., in PLoS Med, vol. 12, n. 12, Dec 2015, pp. e1001924, DOI:10.1371/journal.pmed.1001924, PMID 26694529.
M. Grosshans, J. Mutschler; F. Kiefer, Treatment of cocaine craving with as-needed nalmefene, a partial κ opioid receptor agonist: first clinical experience., in Int Clin Psychopharmacol, vol. 30, n. 4, luglio 2015, pp. 237-8, DOI:10.1097/YIC.0000000000000069, PMID 25647453.
JM. Bidlack, Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence., in Adv Pharmacol, vol. 69, 2014, pp. 387-418, DOI:10.1016/B978-0-12-420118-7.00010-X, PMID 24484983.

espacenet.com

worldwide.espacenet.com

(EN) J Fishman, 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharaceutically accettable salts, su worldwide.espacenet.com, 26 novembre 1971. URL consultato il 12 febbraio 2015.

nih.gov

ncbi.nlm.nih.gov

N. Donnerstag, T. Schneider; A. Lüthi; A. Taegtmeyer; A. Raetz Bravo; A. Mehlig, Severe opioid withdrawal syndrome after a single dose of nalmefene., in Eur J Clin Pharmacol, vol. 71, n. 8, Aug 2015, pp. 1025-6, DOI:10.1007/s00228-015-1884-1, PMID 26050241.
JL. Kaplan, JA. Marx; JJ. Calabro; SL. Gin-Shaw; JD. Spiller; WL. Spivey; GM. Gaddis; N. Zhao; FP. Harchelroad, Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose., in Ann Emerg Med, vol. 34, n. 1, luglio 1999, pp. 42-50, PMID 10381993.
DS. Wang, G. Sternbach; J. Varon, Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine., in J Emerg Med, vol. 16, n. 3, pp. 471-5, PMID 9610980.
C. Palpacuer, B. Laviolle; R. Boussageon; JM. Reymann; E. Bellissant; F. Naudet, Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials., in PLoS Med, vol. 12, n. 12, Dec 2015, pp. e1001924, DOI:10.1371/journal.pmed.1001924, PMID 26694529.
G. Swanbeck, G. Wennersten, Photohemolytic activity of tryptophan and phenylalanine metabolites., in Acta Derm Venereol, vol. 54, n. 2, 1974, pp. 99-104, PMID 4133028.
M. Grosshans, J. Mutschler; F. Kiefer, Treatment of cocaine craving with as-needed nalmefene, a partial κ opioid receptor agonist: first clinical experience., in Int Clin Psychopharmacol, vol. 30, n. 4, luglio 2015, pp. 237-8, DOI:10.1097/YIC.0000000000000069, PMID 25647453.
JM. Bidlack, Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence., in Adv Pharmacol, vol. 69, 2014, pp. 387-418, DOI:10.1016/B978-0-12-420118-7.00010-X, PMID 24484983.

livertox.nih.gov

Drug Record: Nalmefene, in LiverTox, National Library of Medicine, 24 marzo 2016.

oadoi.org

N. Donnerstag, T. Schneider; A. Lüthi; A. Taegtmeyer; A. Raetz Bravo; A. Mehlig, Severe opioid withdrawal syndrome after a single dose of nalmefene., in Eur J Clin Pharmacol, vol. 71, n. 8, Aug 2015, pp. 1025-6, DOI:10.1007/s00228-015-1884-1, PMID 26050241.
C. Palpacuer, B. Laviolle; R. Boussageon; JM. Reymann; E. Bellissant; F. Naudet, Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials., in PLoS Med, vol. 12, n. 12, Dec 2015, pp. e1001924, DOI:10.1371/journal.pmed.1001924, PMID 26694529.
M. Grosshans, J. Mutschler; F. Kiefer, Treatment of cocaine craving with as-needed nalmefene, a partial κ opioid receptor agonist: first clinical experience., in Int Clin Psychopharmacol, vol. 30, n. 4, luglio 2015, pp. 237-8, DOI:10.1097/YIC.0000000000000069, PMID 25647453.
JM. Bidlack, Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence., in Adv Pharmacol, vol. 69, 2014, pp. 387-418, DOI:10.1016/B978-0-12-420118-7.00010-X, PMID 24484983.

web.archive.org

Selincro, su European Medicines Agency. URL consultato il 3 novembre 2015 (archiviato dall'url originale il 4 settembre 2018).